Stocks / NASDAQ / Curis, Inc.

Curis, Inc.

Our Opinion

Curis, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

Company’s product profile: Erivedge®

“Previous animal studies have indicated that Erivedge® is embryotoxic and teratogenic. The FDA-approved labeling thus carries a boxed warning stating that Erivedge® can cause fetal harm when administered to pregnant women and recommends the use of contraception during and after treatment.”

Company Description

Curis, Inc. is a biotechnology company, which is focused on the development and commercialization of innovative drug candidates for the treatment of human cancers. Its pipeline includes is CUDC-907, an orally-available, small molecule inhibitor of histone deacetylase, or HDAC, and phosphatidylinositol-3-kinase, or PI3K enzymes. It conducts research programs both internally and through strategic collaborations. The company was founded on February 14, 2000 and is headquartered in Lexington, MA. [Source: MarketWatch]

Company Website: